This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Zhejiang Bossan Pharmaceutical Co. Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Dawei Ma - Innovator in EGFR Kinase Inhibition
Introduction
Dawei Ma is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical innovations, particularly in the development of EGFR kinase inhibitors. His work is crucial in advancing treatments for various diseases.
Latest Patents
Dawei Ma holds a patent for an EGFR kinase inhibitor and its preparation method and use. The invention provides a compound, as shown in formula (I), which is defined in detail within the patent description. This compound is recognized as an efficient EGFR inhibitor, showcasing its potential in therapeutic applications.
Career Highlights
Dawei Ma is associated with Zhejiang Bossan Pharmaceutical Co. Ltd., where he applies his expertise in drug development. His role in the company has been instrumental in driving forward innovative solutions in the pharmaceutical industry.
Collaborations
Dawei Ma has worked alongside notable colleagues, including Qiang Yu and Junying Yuan. Their collaborative efforts contribute to the advancement of research and development in their field.
Conclusion
Dawei Ma's contributions to the development of EGFR kinase inhibitors highlight his role as an influential inventor in the pharmaceutical sector. His innovative work continues to pave the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile